Bank of Nova Scotia Lowers Stock Position in Mettler-Toledo International, Inc. $MTD

Bank of Nova Scotia lessened its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 14.5% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 10,174 shares of the medical instruments supplier’s stock after selling 1,719 shares during the period. Bank of Nova Scotia’s holdings in Mettler-Toledo International were worth $11,952,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of MTD. California Public Employees Retirement System grew its position in shares of Mettler-Toledo International by 2.9% during the 2nd quarter. California Public Employees Retirement System now owns 35,279 shares of the medical instruments supplier’s stock valued at $41,443,000 after acquiring an additional 997 shares during the period. Cerity Partners LLC boosted its position in Mettler-Toledo International by 10.8% during the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after purchasing an additional 392 shares in the last quarter. Jump Financial LLC grew its holdings in Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after purchasing an additional 125 shares during the period. Great Diamond Partners LLC purchased a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $405,000. Finally, Baird Financial Group Inc. raised its stake in shares of Mettler-Toledo International by 3.1% during the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after buying an additional 40 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Trading Up 2.4%

NYSE:MTD opened at $1,404.68 on Thursday. The company’s 50-day moving average price is $1,398.11 and its 200-day moving average price is $1,289.21. The company has a market cap of $28.70 billion, a P/E ratio of 35.03, a P/E/G ratio of 4.43 and a beta of 1.40. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter in the prior year, the company earned $10.21 EPS. Mettler-Toledo International’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the completion of the sale, the chief executive officer directly owned 3,670 shares in the company, valued at $5,367,375. This represents a 35.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Shawn Vadala sold 1,000 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the transaction, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,990,168. This represents a 15.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 19,565 shares of company stock valued at $28,683,737. 1.94% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on MTD shares. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Bank of America lifted their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Morgan Stanley assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 target price for the company. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Barclays lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a report on Monday, November 10th. Five equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average price target of $1,424.17.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.